Pharmacotherapy of obesity: available medications and drugs under investigation
Obesity is a chronic disease with a continuously rising prevalence that currently affects more
than half a billion people worldwide. Energy balance and appetite are highly regulated via …
than half a billion people worldwide. Energy balance and appetite are highly regulated via …
Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update
K Albracht-Schulte, NS Kalupahana… - The Journal of nutritional …, 2018 - Elsevier
Strategies to reduce obesity have become public health priorities as the prevalence of
obesity has risen in the United States and around the world. While the anti-inflammatory and …
obesity has risen in the United States and around the world. While the anti-inflammatory and …
Long-term weight loss maintenance for obesity: a multidisciplinary approach
L Montesi, M El Ghoch, L Brodosi, S Calugi… - … syndrome and obesity …, 2016 - Taylor & Francis
The long-term weight management of obesity remains a very difficult task, associated with a
high risk of failure and weight regain. However, many people report that they have …
high risk of failure and weight regain. However, many people report that they have …
Probability of 5% or greater weight loss or BMI reduction to healthy weight among adults with overweight or obesity
L Kompaniyets, DS Freedman, B Belay… - JAMA Network …, 2023 - jamanetwork.com
Importance Information on the probability of weight loss among US adults with overweight or
obesity is limited. Objective To assess the probability of 5% or greater weight loss, 10% or …
obesity is limited. Objective To assess the probability of 5% or greater weight loss, 10% or …
Reduced obesity, diabetes, and steatosis upon cinnamon and grape pomace are associated with changes in gut microbiota and markers of gut barrier
M Van Hul, L Geurts, H Plovier… - American Journal …, 2018 - journals.physiology.org
Increasing evidence suggests that polyphenols have a significant potential in the prevention
and treatment of risk factors associated with metabolic syndrome. The objective of this study …
and treatment of risk factors associated with metabolic syndrome. The objective of this study …
Safety and tolerability of new-generation anti-obesity medications: a narrative review
DK Patel, FC Stanford - Postgraduate medicine, 2018 - Taylor & Francis
The prevalence of obesity and associated comorbidities is rising. Despite their weight-loss
efficacy, new generation anti-obesity medications are only prescribed to a minority of adults …
efficacy, new generation anti-obesity medications are only prescribed to a minority of adults …
PCSK1 mutations and human endocrinopathies: from obesity to gastrointestinal disorders
P Stijnen, B Ramos-Molina, S O'Rahilly… - Endocrine …, 2016 - academic.oup.com
Abstract Prohormone convertase 1/3, encoded by the PCSK1 gene, is a serine
endoprotease that is involved in the processing of a variety of proneuropeptides and …
endoprotease that is involved in the processing of a variety of proneuropeptides and …
[HTML][HTML] Current status of intragastric balloon for obesity treatment
SH Kim, HJ Chun, HS Choi, ES Kim… - World journal of …, 2016 - ncbi.nlm.nih.gov
Endoscopic bariatric therapy may be a useful alternative to pharmacological treatment for
obesity, and it provides greater efficacy with lower risks than do conventional surgical …
obesity, and it provides greater efficacy with lower risks than do conventional surgical …
The pharmacological management of metabolic syndrome
J Rask Larsen, L Dima, CU Correll… - Expert review of clinical …, 2018 - Taylor & Francis
Introduction: The metabolic syndrome includes a constellation of several well-established
risk factors, which need to be aggressively treated in order to prevent overt type 2 diabetes …
risk factors, which need to be aggressively treated in order to prevent overt type 2 diabetes …
Metabolic health and weight: Understanding metabolically unhealthy normal weight or metabolically healthy obese patients
H Mathew, OM Farr… - Metabolism: clinical and …, 2015 - pmc.ncbi.nlm.nih.gov
Obesity is most commonly defined as a BMI of over 30kg/m2. Typical classification is into
categories of Class I (BMI> 30 kg/m2), Class II (BMI equal to or over 35 kg/m2) and Class III …
categories of Class I (BMI> 30 kg/m2), Class II (BMI equal to or over 35 kg/m2) and Class III …